.....................  ......
Society Statement
.....  
         
 HOME

 SITEMAP

 MAILINGLIST

 LINKS

 GLOSSARY

 FAQ

 
Prof. Dr. Georg Schöfbänker

In contrast to the medical and industrial applications of biotechnologies and the general sociopolitical consequences that have already begun emerging from the increasing use of discoveries in the field of biotechnology such as biometric processes, the "genetic fingerprint," or genetic diagnostics, the danger of the deployment of biological weapons has been known for decades. Even during the Second World War, experiments were being run with a number of different pathogens using sheep on an British island in the North Sea. As far as we know, biological weapons-also known as the poor man's atom bomb-have been used only once to date-by the Japanese Armed Forces during the Second World War. The so-called Gulf War Syndrome that was diagnosed among US veterans was traced back at least in part to inoculations against biological weapons such as anthrax pathogens. Lately, threat scenarios have been circulating within intelligence circles whereby it is said to be possible to develop warfare agents which act only on genetic characteristics of particular ethnic groups, so that only the "enemy" would be effected by such weapons.

Regardless of whether this is a case of scientific nonsense or a real option of future weapons development, we know only too well from the past that the military basically either gets started on its own with R&D on all new technologies (atomic weapons) or at least adapts them for their own purposes (infowar). However, it is a matter of fact that a number of new weapons could be developed by genetically manipulating the great many agents of bacteriological warfare that already exist and for which there are no known defenses. Indeed, the community of nations has passed an international disarmament treaty, the "Biological and Toxin Weapons Convention," whereby it is agreed to neither produce nor use them, though without the verification procedures that are usually in place with other types of weapons. Nevertheless, there have been numerous violations of this accord, the best-known case being Iraq's production of agents of biological warfare. It is less well-known that the former USSR- although it had ratified the convention in 1975-also developed genetically-manipulated biological weapons, as reported by Kenneth Alibek, a Russian weapons technologist who defected in 1992. In recent months, there has been an outbreak of mass hysteria connected with "bioterrorism" and "bioarmageddon" in the US. These scenarios feature terrorists-usually foreigners- deploying biological weapons in that country. To counter this threat, the Clinton Administration issued a directive in May 1998 and made $150 million in funding available.